Virksomhedsstatus | NORMAL. |
Sidst opdateret den 21.07.2015 og
angivet som gældende fra 13.07.2015 (3218
dage). |
Ingen historik.
Branche | Agenturhandel med specialiseret varesortiment i.a.n (461800). |
Sidst opdateret den 14.06.2023 og
angivet som gældende fra 01.01.2023 (489
dage). |
Historik | Start | Stop |
---|
Agenturhandel med specialiseret varesortiment i.a.n (461800) | 01.01.2023 | |
Fremstilling af farmaceutiske præparater (212000) | 18.08.2015 | 31.12.2022 |
Uoplyst (999999) | 13.07.2015 | 17.08.2015 |
Revisionfravalgt | false. |
Sidst opdateret den 12.07.2016 og
angivet som gældende fra 12.07.2016 (2853
dage). |
Historik | Start | Stop |
---|
false | 12.07.2016 | |
true | 13.07.2015 | 11.07.2016 |
Revisor | KPMG P/S |
Sidst opdateret den 12.07.2016 og
angivet som gældende fra 12.07.2016 (2853
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Navne | Ascensia Diabetes Care Denmark ApS. |
Sidst opdateret den 20.08.2015 og
angivet som gældende fra 18.08.2015 (3182
dage). |
Historik | Start | Stop |
---|
Ascensia Diabetes Care Denmark ApS | 18.08.2015 | |
KR 1809 ApS | 13.07.2015 | 17.08.2015 |
Tegningsregel | Selskabet tegnes af bestyrelsesformanden alene eller af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse. |
Sidst opdateret den 11.11.2019 og
angivet som gældende fra 07.11.2019 (1640
dage). |
Fortolkning
(3 tegningsmuligheder)
| formanden |
2 bestyrelsesmedlemmer + |
bestyrelsen |
Historik | Start | Stop |
---|
Selskabet tegnes af bestyrelsesformanden alene eller af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse | 07.11.2019 | |
Selskabet tegnes af den samlede direktion | 13.07.2015 | 06.11.2019 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:KPMG P/S Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these rules and requirements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Ascensia Diabetes Care Denmark ApS for the financial year 1 April 2022 - 31 March 2023, comprising income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the financial position of the Company's assets, liabilites and financial position at 31 March 2023, and of the results of the Company's operations for the financial year 1 April 2022 - 31 March 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review.
Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.